Periodontal Disease Market to Reach New Heights in Growth by 2032, DelveInsight Predicts | Geistlich Pharma AG, Noveome Biotherapeutics, Amyndas Pharmaceuticals

The Key Periodontal Disease Companies in the market include - Geistlich Pharma AG, Noveome Biotherapeutics, Amyndas Pharmaceuticals, and others.

The Periodontal Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Periodontal Disease pipeline products will significantly revolutionize the Periodontal Disease market dynamics.

DelveInsight's "Periodontal Disease Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Periodontal Disease, historical and forecasted epidemiology as well as the Periodontal Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Periodontal Disease market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

To Know in detail about the Periodontal Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Periodontal Disease Market Forecast [https://www.delveinsight.com/sample-request/periodontal-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Some of the key facts of the Periodontal Disease Market Report:

*
The Periodontal Disease market size is anticipated to grow with a significant CAGR during the study period (2019-2032)

*
According to the Centers for Disease Control and Prevention (CDC), almost 50 percent of adults in the US, over the age of 30, have the advanced form of periodontal disease, or gum disease. The data confirmed that gum disease is prevalent in the United States. Americans bear a very heavy burden when it comes to periodontal disease

*
In a study by Abe et al. (2022), periodontal disease is currently the leading cause (40.4% in men and 34.9% in women), surpassing caries (30.2% in men and 29.0% in women)

*
Key Periodontal Disease Companies: Geistlich Pharma AG, Noveome Biotherapeutics, Amyndas Pharmaceuticals, and others

*
Key Periodontal Disease Therapies: PerioSept(r), ST266, AMY 101, and others

*
The Periodontal Disease epidemiology based on gender analyzed that males are slightly more affected in the case of Periodontal Disease

Periodontal Disease Overview

Periodontal disease, also known as gum disease, is a chronic inflammatory condition that affects the tissues surrounding and supporting the teeth, primarily the gums, and the bone that holds the teeth in place. If left untreated, it can lead to tooth loss and has been associated with other systemic health issues such as heart disease and diabetes.

Get a Free sample for the Periodontal Disease Market Report

https://www.delveinsight.com/report-store/periodontal-disease-market [https://www.delveinsight.com/report-store/periodontal-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Periodontal Disease Market

The dynamics of the Periodontal Disease market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecast period 2019-2032.

"Large proportions of patients require care for periodontal disease and operative management of caries. While there is no significant difference between preventive treatment planned and received, there are significant differences in treatment planned and received for all types of restorative care."

Periodontal Disease Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Periodontal Disease Epidemiology Segmentation:

The Periodontal Disease market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:

*
Total Prevalence of Periodontal Disease

*
Prevalent Cases of Periodontal Disease by severity

*
Gender-specific Prevalence of Periodontal Disease

*
Diagnosed Cases of Episodic and Chronic Periodontal Disease

Download the report to understand which factors are driving Periodontal Disease epidemiology trends @ Periodontal Disease Epidemiological Insights [https://www.delveinsight.com/sample-request/periodontal-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Periodontal Disease Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Periodontal Disease market or expected to get launched during the study period. The analysis covers Periodontal Disease market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Periodontal Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Periodontal Disease Therapies and Key Companies

*
PerioSept(r): Geistlich Pharma AG

*
ST266: Noveome Biotherapeutics

*
AMY 101: Amyndas Pharmaceuticals

To know more about Periodontal Disease treatment, visit @ Periodontal Disease Medications [https://www.delveinsight.com/sample-request/periodontal-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Periodontal Disease Market Strengths

*
Late-stage pipeline drugs such as Faricimab, Beovu and KSI-301 are some of the potential emerging therapies that have shown promising results and expected to improve the dosing interval

Periodontal Disease Market Unmet Needs

*
Need of novel and effective treatment for periodontal disease

*
Need to develop management guidelines for adolescents and adults with periodontal disease

*
Need for reassessment of doses for periodontal disease

Scope of the Periodontal Disease Market Report

*
Study Period: 2019-2032

*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

*
Key Periodontal Disease Companies: Geistlich Pharma AG, Noveome Biotherapeutics, Amyndas Pharmaceuticals, and others

*
Key Periodontal Disease Therapies: PerioSept(r), ST266, AMY 101, and others

*
Periodontal Disease Therapeutic Assessment: Periodontal Disease current marketed and Periodontal Disease emerging therapies

*
Periodontal Disease Market Dynamics: Periodontal Disease market drivers and Periodontal Disease market barriers

*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies

*
Periodontal Disease Unmet Needs, KOL's views, Analyst's views, Periodontal Disease Market Access and Reimbursement

Discover more about therapies set to grab major Periodontal Disease market share @ Periodontal Disease Treatment Landscape [https://www.delveinsight.com/sample-request/periodontal-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Table of Contents

1. Periodontal Disease Market Report Introduction

2. Executive Summary for Periodontal Disease

3. SWOT analysis of Periodontal Disease

4. Periodontal Disease Patient Share (%) Overview at a Glance

5. Periodontal Disease Market Overview at a Glance

6. Periodontal Disease Disease Background and Overview

7. Periodontal Disease Epidemiology and Patient Population

8. Country-Specific Patient Population of Periodontal Disease

9. Periodontal Disease Current Treatment and Medical Practices

10. Periodontal Disease Unmet Needs

11. Periodontal Disease Emerging Therapies

12. Periodontal Disease Market Outlook

13. Country-Wise Periodontal Disease Market Analysis (2019-2032)

14. Periodontal Disease Market Access and Reimbursement of Therapies

15. Periodontal Disease Market Drivers

16. Periodontal Disease Market Barriers

17. Periodontal Disease Appendix

18. Periodontal Disease Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=periodontal-disease-market-to-reach-new-heights-in-growth-by-2032-delveinsight-predicts-geistlich-pharma-ag-noveome-biotherapeutics-amyndas-pharmaceuticals]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.